Most popular ETFs | ||||||
iShares Core MSCI World UCITS ETF USD (Acc) | IE00B4L5Y983 | Equity | ETF | Profile | Index | |
Xtrackers MSCI Emerging Markets UCITS ETF 1C | IE00BTJRMP35 | Equity | ETF | Profile | Index | |
Vanguard FTSE All-World UCITS ETF Distributing | IE00B3RBWM25 | Equity | ETF | Profile | Index | |
iShares Global Clean Energy UCITS ETF USD (Dist) | IE00B1XNHC34 | Equity | ETF | Profile | Index | |
HSBC FTSE 100 UCITS ETF GBP | IE00B42TW061 | Equity | ETF | Profile | Index |
Most popular categories |
Equity, World |
Equity, Dividend strategy |
Bonds, UK Gilts |
The VanEck Genomics and Healthcare Innovators UCITS ETF A seeks to track the MVIS Global Future Healthcare ESG index. The MVIS Global Future Healthcare ESG index tracks companies worldwide that are active in the genomics or e-healthcare industries. The stocks included are filtered according to ESG criteria (environmental, social and corporate governance).
MVIS Global Future Healthcare ESG (1)
Equity (1110) World (331) Health Care (17) Innovation (13)
Replication |
Physical (Full replication) |
Legal structure | ETF |
Strategy risk | Long-only |
Fund currency | USD |
Currency risk |
Currency unhedged |
Volatility 1 year (in GBP) | - - |
Inception/ Listing Date | 2 September 2022 |
Distribution policy | Accumulating |
Distribution frequency | - |
Fund domicile | Ireland |
Fund Structure | Open-ended Investment Company (OEIC) |
UCITS compliance | Yes |
Fund Provider | VanEck |
Administrator | State Street Custodial Services (Ireland) Limited |
Investment Advisor | VanEck Asset Management B.V. |
Custodian Bank | State Street Custodial Services (Ireland) Limited |
Revision Company | KPMG Ireland |
Fiscal Year End | 31 December |
Swiss representative | FIRST INDEPENDENT FUND SERVICES AG |
Swiss paying agent | Helvetische Bank AG |
Germany | 30% tax rebate |
Switzerland | ESTV Reporting |
Austria | Non-Tax Reporting Fund |
UK | No UK Reporting |
Indextype | Total return index |
Swap counterparty | - |
Collateral manager | |
Securities lending | No |
Securities lending counterparty |
Below you find information about the composition of the VanEck Genomics and Healthcare Innovators UCITS ETF A.
VERTEX PHARMACEUTICALS ORD |
8.11%
|
MODERNA INC |
7.84%
|
REGENERON PHARMACEUTICALS INC |
6.92%
|
ILLUMINA INC |
6.14%
|
DEXCOM INC |
5.88%
|
VEEVA SYSTEMS INC -A |
5.14%
|
BIONTECH SE ADR |
4.83%
|
ALNYLAM PHARMACEUTICALS ORD |
4.38%
|
M3 ORD |
3.95%
|
QIAGEN NV |
3.41%
|
Other |
100.00%
|